Found: 11
Select item for more details and to access through your institution.
Nucleophosmin1 Is a Negative Regulator of the Small GTPase Rac1.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068477
- By:
- Publication type:
- Article
European Conditional Marketing Authorization in a Rapidly Evolving Treatment Landscape: A Comprehensive Study of Anticancer Medicinal Products in 2006–2020.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 1, p. 148, doi. 10.1002/cpt.2906
- By:
- Publication type:
- Article
Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation.
- Published in:
- British Journal of Haematology, 2000, v. 111, n. 2, p. 674, doi. 10.1046/j.1365-2141.2000.02351.x
- By:
- Publication type:
- Article
The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 628, doi. 10.1093/oncolo/oyad119
- By:
- Publication type:
- Article
EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 983, doi. 10.1002/onco.13892
- By:
- Publication type:
- Article
EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 242, doi. 10.1002/onco.13685
- By:
- Publication type:
- Article
EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e976, doi. 10.1634/theoncologist.2019-0898
- By:
- Publication type:
- Article
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- Oncologist, 2018, v. 23, n. 5, p. 631, doi. 10.1634/theoncologist.2017-0301
- By:
- Publication type:
- Article
The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
- Published in:
- Oncologist, 2016, v. 21, n. 1, p. 102, doi. 10.1634/theoncologist.2015-0276
- By:
- Publication type:
- Article
Separation of G-CSF-mobilized PBSC transplants by counterflow centrifugal elutriation: modest enrichment of CD34<sup>+</sup> cells but no loss of primitive haemopoietic progenitors.
- Published in:
- British Journal of Haematology, 1997, v. 99, n. 1, p. 47, doi. 10.1046/j.1365-2141.1997.3333147.x
- By:
- Publication type:
- Article